European heart journal

publication venue for

2018 ESC/EACTS Guidelines on myocardial revascularization. 2019
Aneurysmal left sinus of Valsalva in Marfan's syndrome. 2018
Non-invasive FFRCT revealing severe inducible ischaemia in an anomalous right coronary artery. 2017
An unusual case of right-sided heart failure caused by giant sinus of Valsalva aneurysm obstructing right ventricular outflow tract. 2014
ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death--executive summary: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. 2006
The recognition and management of hyperlipidaemia in adults: A policy statement of the European Atherosclerosis Society. 1988
Radial artery vs. internal thoracic artery or saphenous vein grafts: 15-year results of the RAPCO trials.. 44. 2023
Biomarkers and cardiovascular outcomes in chimeric antigen receptor T-cell therapy recipients.. 44. 2023
Iron deficiency in pulmonary vascular disease: pathophysiological and clinical implications.. 44. 2023
In memoriam: Professor Domenico Pagano.. 44. 2023
Single versus multiple arterial grafting in diabetic patients at 10 years: the Arterial Revascularization Trial.. 43. 2022
Post-operative atrial fibrillation and risk of heart failure hospitalization.. 43. 2022
Left main revascularization: an evidence-based reconciliation.. 43. 2022
Lung function impairment and risk of incident heart failure: the NHLBI Pooled Cohorts Study.. 43. 2022
Single or multiple arterial bypass graft surgery vs. percutaneous coronary intervention in patients with three-vessel or left main coronary artery disease.. 43. 2022
Remnant cholesterol predicts cardiovascular disease beyond LDL and ApoB: a primary prevention study.. 42. 2021
Retractions in medicine: the tip of the iceberg.. 42. 2021
Mammographic features are associated with cardiometabolic disease risk and mortality.. 42. 2021
Prognostically relevant periprocedural myocardial injury and infarction associated with percutaneous coronary interventions: a Consensus Document of the ESC Working Group on Cellular Biology of the Heart and European Association of Percutaneous Cardiovascular Interventions (EAPCI).. 42. 2021
The association between coronary graft patency and clinical status in patients with coronary artery disease.. 42. 2021
Pregnancy-associated arterial dissections: a nationwide cohort study.. 41. 2020
Cardiovascular magnetic resonance in immune checkpoint inhibitor-associated myocarditis.. 41. 2020
Impact of renin-angiotensin system inhibitors on clinical outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement: an analysis of from the PARTNER 2 trial and registries.. 41. 2020
Low and elevated B-type natriuretic peptide levels are associated with increased mortality in patients with preserved ejection fraction undergoing transcatheter aortic valve replacement: an analysis of the PARTNER II trial and registry.. 41. 2020
Machine learning of clinical variables and coronary artery calcium scoring for the prediction of obstructive coronary artery disease on coronary computed tomography angiography: analysis from the CONFIRM registry.. 41. 2020
Sex-based differences in outcomes, 30-day readmissions, and costs following catheter ablation of atrial fibrillation: the United States Nationwide Readmissions Database 2010-14.. 40. 2019
Association between regional body fat and cardiovascular disease risk among postmenopausal women with normal body mass index.. 40. 2019
Impact of preoperative fractional flow reserve on arterial bypass graft anastomotic function: the IMPAG trial.. 40. 2019
New-onset left bundle branch block after transcatheter aortic valve replacement is associated with adverse long-term clinical outcomes in intermediate-risk patients: an analysis from the PARTNER II trial.. 40. 2019
Impact of large periprocedural myocardial infarction on mortality after percutaneous coronary intervention and coronary artery bypass grafting for left main disease: an analysis from the EXCEL trial.. 40. 2019
Outcomes of transcatheter mitral valve replacement for degenerated bioprostheses, failed annuloplasty rings, and mitral annular calcification.. 40. 2019
An update on the journey towards precision medicine in cardiology.. 39. 2018
Associations between very low concentrations of low density lipoprotein cholesterol, high sensitivity C-reactive protein, and health outcomes in the Reasons for Geographical and Racial Differences in Stroke (REGARDS) study.. 39. 2018
2018 ESC/ESH Guidelines for the management of arterial hypertension.. 39. 2018
Blood pressure, heart rate, and mortality in chronic obstructive pulmonary disease: the SUMMIT trial.. 39. 2018
SCN5A mutations in 442 neonates and children: genotype-phenotype correlation and identification of higher-risk subgroups.. 39. 2018
The heart regulates the endocrine response to heart failure: cardiac contribution to circulating neprilysin.. 39. 2018
BDNFVal66met polymorphism: a potential bridge between depression and thrombosis.. 38. 2017
A view from the side-line.. 37. 2016
Cardiovascular precision medicine: hope or hype?. 36. 2015
Current worldwide nuclear cardiology practices and radiation exposure: results from the 65 country IAEA Nuclear Cardiology Protocols Cross-Sectional Study (INCAPS).. 36. 2015
Expression of functional tissue factor by neutrophil extracellular traps in culprit artery of acute myocardial infarction.. 36. 2015
Sustainable Development Goals and the future of cardiovascular health. A statement from the Global Cardiovascular Disease Taskforce.. 35. 2014
Establishing reference values for central blood pressure and its amplification in a general healthy population and according to cardiovascular risk factors.. 35. 2014
Inhibition of delta-protein kinase C by delcasertib as an adjunct to primary percutaneous coronary intervention for acute anterior ST-segment elevation myocardial infarction: results of the PROTECTION AMI Randomized Controlled Trial.. 35. 2014
Contrast-induced acute kidney injury after primary percutaneous coronary intervention: results from the HORIZONS-AMI substudy.. 35. 2014
Cost-effectiveness of apixaban vs. current standard of care for stroke prevention in patients with atrial fibrillation.. 35. 2014
High proportion of patients with end-stage heart failure regardless of aetiology demonstrates anti-cardiac antibody deposition in failing myocardium: humoral activation, a potential contributor of disease progression.. 35. 2013
Cardiologists urged to reduce inappropriate radiation exposure.. 34. 2013
Hypertensive target organ damage predicts incident diabetes mellitus.. 34. 2013
Lack of protective role of HDL-C in patients with coronary artery disease undergoing elective coronary artery bypass grafting.. 34. 2013
Percutaneous left atrial appendage closure for stroke prevention in patients with atrial fibrillation: an assessment of net clinical benefit.. 33. 2012
Our time: a call to save preventable death from cardiovascular disease (heart disease and stroke).. 33. 2012
The impact of height on the risk of atrial fibrillation: the Cardiovascular Health Study.. 33. 2012
Mid-regional pro-atrial natriuretic peptide and pro-adrenomedullin testing for the diagnostic and prognostic evaluation of patients with acute dyspnoea.. 33. 2012
Multidisciplinary care of patients receiving cardiac resynchronization therapy is associated with improved clinical outcomes.. 33. 2012
Prognostic impact of a chronic total occlusion in a non-infarct-related artery in patients with ST-segment elevation myocardial infarction: 3-year results from the HORIZONS-AMI trial.. 33. 2012
High-sensitivity C-reactive protein, statin therapy, and risks of atrial fibrillation: an exploratory analysis of the JUPITER trial.. 33. 2011
All-cause and cardiovascular mortality in relation to changing heart rate during treatment of hypertensive patients with electrocardiographic left ventricular hypertrophy.. 31. 2010
QRS duration predicts sudden cardiac death in hypertensive patients undergoing intensive medical therapy: the LIFE study.. 30. 2009
Prior polyvascular disease: risk factor for adverse ischaemic outcomes in acute coronary syndromes.. 30. 2009
Endothelial progenitor cell levels in obese men with the metabolic syndrome and the effect of simvastatin monotherapy vs. simvastatin/ezetimibe combination therapy.. 29. 2008
Preserved left ventricular twist and circumferential deformation, but depressed longitudinal and radial deformation in patients with diastolic heart failure.. 29. 2008
Reperfusion after primary angioplasty for ST-elevation myocardial infarction: predictors of success and relationship to clinical outcomes in the APEX-AMI angiographic study.. 29. 2008
Left ventricular mass predicts heart failure not related to previous myocardial infarction: the Cardiovascular Health Study.. 29. 2008
Effect of nitric oxide synthase inhibition on haemodynamics and outcome of patients with persistent cardiogenic shock complicating acute myocardial infarction: a phase II dose-ranging study.. 28. 2007
Should angiotensin-converting enzyme-inhibitors be used to improve outcome in patients with coronary artery disease and 'preserved' left ventricular function?. 27. 2006
Predictors of revascularization method and long-term outcome of percutaneous coronary intervention or repeat coronary bypass surgery in patients with multivessel coronary disease and previous coronary bypass surgery.. 27. 2005
Left ventricular concentric geometry is associated with impaired relaxation in hypertension: the HyperGEN study.. 26. 2004
Survival after aortic valve replacement for aortic stenosis: does left ventricular mass regression have a clinical correlate?. 26. 2004
Abciximab-facilitated percutaneous coronary intervention and long-term survival--a prospective single-center registry.. 24. 2003
Frequency and long-term impact of myonecrosis after coronary stenting.. 23. 2002
Patients with acute coronary syndromes without persistent ST elevation undergoing percutaneous coronary intervention benefit most from early intervention with protection by a glycoprotein IIb/IIIa receptor blocker.. 23. 2002
Application of the National Cholesterol Education Program and joint European treatment criteria and clinical benefit in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS).. 21. 2000
Factors associated with failure of medical therapy in patients with unstable angina and non-Q wave myocardial infarction. A TIMI-IIIB database study.. 20. 1999
Platelet alpha 2 adrenoceptor characteristics during the morning increase in platelet aggregability.. 13. 1992
Adrenergic nervous system and left ventricular mass in primary hypertension.. 10. 1989
Beneficial effects of diltiazem combined with beta blockade in angina pectoris.. 6. 1985
Beneficial effect of adding nifedipine to beta-adrenergic blocking therapy in angina pectoris.. 3. 1982
Beneficial effect of enhanced myocardial carbohydrate utilisation after oxfenicine (L-hydroxyphenylglycine) in angina pectoris.. 1. 1980
Circadian influences, time of hospitalization, and prognosis in acute myocardial infarction. 2019
A double blind, randomized study on platelet aggregation in patients treated with a daily dose of 150 or 75 mg of clopidogrel for 30 days. 2007
Relationship between blood pressure and blood viscosity. 1993
Left main revascularization: breaking through the sounds of silence.. 43. 2022
The conundrum of the treatment for left main coronary disease.. 41. 2020
Genetic variants and disease: correlate or cause?. 37. 2015
High resting heart rate predicts mortality, disability, and cognitive decline in patients after ischaemic stroke: time for additional selective I(f) channel inhibitor trials?. 33. 2012
More about plasma renin and cardiovascular mortality.. 32. 2011
Tissue Doppler imaging for the pre-clinical diagnosis of cardiomyopathy.. 25. 2004
Epicardial versus microcirculatory dissociation.. 23. 2002
Troponin, embolization and restoration of microvascular integrity.. 21. 2000
Progress in exercise electrocardiography.. 17. 1996
Postoperative atrial fibrillation: from mechanisms to treatment. 2023
ESC/EACTS vs. ACC/AHA guidelines for the management of severe aortic stenosis. 2023
Left main coronary disease: evolving management concepts. 2022
Sex differences in outcomes after coronary artery bypass grafting: a pooled analysis of individual patient data. 2021
Procedural myocardial injury, infarction and mortality in patients undergoing elective PCI: a pooled analysis of patient-level data. 2021
Mortality after drug-eluting stents vs. coronary artery bypass grafting for left main coronary artery disease: a meta-analysis of randomized controlled trials. 2020
Clinical impact of conduction disturbances in transcatheter aortic valve replacement recipients: a systematic review and meta-analysis. 2020
Clinical applications of machine learning in cardiovascular disease and its relevance to cardiac imaging. 2019
Validation of non-invasive central blood pressure devices: ARTERY Society task force consensus statement on protocol standardization. 2017
Three, six, or twelve months of dual antiplatelet therapy after DES implantation in patients with or without acute coronary syndromes: an individual patient data pairwise and network meta-analysis of six randomized trials and 11 473 patients. 2017
The impact of proprotein convertase subtilisin-kexin type 9 serine protease inhibitors on lipid levels and outcomes in patients with primary hypercholesterolaemia: a network meta-analysis. 2015
The future of transcatheter mitral valve interventions: competitive or complementary role of repair vs. replacement? 2015
The effect of statin therapy on heart failure events: a collaborative meta-analysis of unpublished data from major randomized trials. 2015
Central blood pressure: current evidence and clinical importance. 2014
Review of surgical prosthetic paravalvular leaks: diagnosis and catheter-based closure. 2012
Cardiovascular safety of drugs not intended for cardiovascular use: need for a new conceptual basis for assessment and approval. 2007
Platelet glycoprotein IIb/IIIa inhibition in acute coronary syndromes. Gradient of benefit related to the revascularization strategy. 2002
Description of patients undergoing high risk angioplasty. Analyses of various databases. 1995
Early clinical experience with integrelin, an inhibitor of the platelet glycoprotein IIb/IIIa integrin receptor. 1995
Management of the patient with left ventricular hypertrophy. 1993
Methods for detection of left ventricular hypertrophy: application to hypertensive heart disease. 1993
Measurement of cardiac output by M-mode and two-dimensional echocardiography: application to patients with hypertension. 1990

VIVO Weill Cornell Medical College

European heart journal Journal

Overview

publication venue for

Identity

ISO Abbreviation

Linking ISSN

International Standard Serial Number (ISSN)

Electronic International Standard Serial Number (EISSN)